Approval · Notice of Compliance 4476 · 1996
WELLFERON: Notice of Compliance 4476
Issued December 24, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4476
- Date
- December 24, 1996
- Company
- Glaxo Wellcome Inc.Mississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication for the treatment of chronic hepatitis B infection
- Therapeutic class
- Biological response modifier
Products in this notice
Medicinal ingredients
- INTERFERON ALPHA-N1 (INS) 3 M per ML
- INTERFERON ALPHA-N1 (INS) 10 M per ML
- INTERFERON ALPHA-N1 (INS) 5 M per ML